1. Issues of method-specificity and -dependency of blood pressure data: lack of reporting of methodological specifications

   • C. de Mey
   • D. Enterling

   SPECIAL ARTICLE Pages: 295 - 297

2. European network for the case–population surveillance of rare diseases (Euronet). A prospective feasibility study

   • D. Capellà
   • J.-R. Laporte
   • M. Rawlins

   PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 299 - 302

3. Analgesic efficacy of ibuprofen alone and in combination with codeine or caffeine in post-surgical pain: a meta-analysis

   • A. Li Wan Po
   • W. Y. Zhang

   CLINICAL TRIALS Pages: 303 - 311

4. Rubber emboli

   • W. H. Seto
   • P. T. Y. Ching
   • C. R. Kumana

   PHARMACODYNAMICS Pages: 313 - 315

5. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults

   • A. M. Wilson
   • D. J. Clark
   • B. J. Lipworth

   PHARMACODYNAMICS Pages: 317 - 320

6. Lack of acetaminophen ceiling effect on R-III nociceptive flexion reflex

   • V. Piguet
   • J. Desmeules
   • P. Dayer

   PHARMACODYNAMICS Pages: 321 - 324

7. Variability of morphine disposition during long-term subcutaneous infusion in terminally ill cancer patients

   • A. Vermeire
   • J. P. Remon
   • M. G. Bogaert

   PHARMACOKINETICS AND DISPOSITION Pages: 325 - 330

8. Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure

   • R. Candinas
   • J. Frielingsdorf
   • F. Follath

   PHARMACOKINETICS AND DISPOSITION Pages: 331 - 336

9. Determination of population pharmacokinetic parameters for amikacin in neonates using mixed-effect models

   • J. H. Botha
   • M. J. du Preez
   • M. Adhikari

   PHARMACOKINETICS AND DISPOSITION Pages: 337 - 341

10. Changes in urinary 6β-hydroxycortisol/cortisol ratio after birth in human neonates

    • H. Nakamura
    • M. Hirai
    • M. Kitada

    PHARMACOKINETICS AND DISPOSITION Pages: 343 - 346

11. Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patients

    • K. Otani
    • G. Tybring
    • K. Sugawara

    PHARMACOKINETICS AND DISPOSITION Pages: 347 - 349

12. The pharmacokinetics of oxybutynin is unaffected by gender and contraceptive steroids

    • E. Lukkari
    • T. Hakonen
    • P. J. Neuvonen

    PHARMACOKINETICS AND DISPOSITION Pages: 351 - 354

13. Intraindividual variability of paracetamol absorption kinetics after a semi-solid meal in healthy volunteers

    • G. Paintaud
    • P. Thibault
    • P. Carayon

    PHARMACOKINETICS AND DISPOSITION Pages: 355 - 359

14. A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers

    • D. Schrenk
    • D. Brockmeier
    • M. Eichelbaum

    PHARMACOKINETICS AND DISPOSITION Pages: 361 - 367

15. Company observational post-marketing studies: drug risk assessment and drug research in special populations – a study-based analysis

    • J. Hasford
    • T. Lamprecht

    LETTER TO THE EDITORS Pages: 369 - 371

16. Estimation of drug concentrations in plasma from urinary excretion data: an illustration based on salbutamol

    • D. W. Boulton
    • J. P. Fawcett

    LETTER TO THE EDITORS Pages: 373 - 374

17. Pharmacokinetic and bioequivalence evaluation of two generic formulations of oral artesunate

    • K. Na-Bangchang
    • J. Karbwang
    • R. Ubalee

    LETTER TO THE EDITORS Pages: 375 - 376